Chemotherapy News and Research

Latest Chemotherapy News and Research

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

Adoptive cell transfer is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable of targeting their tumor, selecting the more active T cells and expanding those in the lab, and then transfusing them back into patients.

30 Nov 2018

UA researchers discover promising lead in genetic approach to treating deadly brain cancer

Glioblastoma, a deadly brain cancer that has grabbed headlines for claiming the lives of Sens. Edward Kennedy and John McCain, could be "tricked" into sparing more of its victims.

30 Nov 2018

Researchers discover pathway for enhancing the self-repair efforts of injured kidneys

A team of researchers led by Jonathan Stamler, MD, of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, has discovered a pathway for enhancing the self-repair efforts of injured kidneys.

29 Nov 2018

Platelets grown from stem cells could reduce the reliance on donated platelets

Researchers have developed a way to grow human platelets in the laboratory from stem cells derived from fat tissue. The achievement, reported today in the journal Blood, suggests manufactured platelets could eventually reduce the reliance on donated platelets to help patients with cancer and other disorders.

29 Nov 2018

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

The U.S. Food and Drug Administration today approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin's lymphoma (NHL) to be used as a single agent or in combination with chemotherapy.

29 Nov 2018

Researchers examine the experiences of veterans receiving both cancer treatment and hospice care

Veterans Health Administration hospitals offer something Medicare does not: In some cases, treatments meant to alter the course of a disease can be offered along with hospice care.

28 Nov 2018

New nanoscale technique developed to get more information from the blood of cancer patients

A technique to get more information from the blood of cancer patients than previously possible has been developed.

28 Nov 2018

New therapeutic drug monitoring service could benefit children with cancer

Children with cancer are to benefit nationally from a service which for the first time will allow doctors to personalize their treatment.

28 Nov 2018

Study: Some bowel cancer patients in the UK have to wait more than a year to begin treatment

It can take up to a year for some bowel cancer patients in the UK to start treatment, according to international research co-ordinated by Cancer Research UK and published in BMJ Open.

27 Nov 2018

Research may pave way for development of potent weapons against cancer

Despite significant advances in cancer research, the disease continues to exact a devastating toll. Because cancer is a disease of the body's own cells, which mutate and develop under evolutionary pressure, conventional treatments like chemotherapy and radiation often leave behind a residue of resistant cells that go on to expand and wreak havoc.

27 Nov 2018

Scientists identify key component of microscopic machinery that drives cell death

An important component of the microscopic machinery that drives cell death has been identified by Walter and Eliza Hall Institute scientists.

27 Nov 2018

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Some severe forms of leukemia develop because proteins on the epigenetic level lose their regulative function. Now, in a broad international collaboration, UK researchers have identified molecules that can effectively inhibit the dysregulated proteins.

27 Nov 2018

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

One of the most successful techniques to combat multidrug resistance in cancer cells is the downregulation of those genes responsible for drug resistance.

22 Nov 2018

FDA approves new treatment for AML patients

The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75 years of age or older or who have other chronic health conditions or diseases (comorbidities) that may preclude the use of intensive chemotherapy.

22 Nov 2018

Chemotherapy News and Research

Latest Chemotherapy News and Research

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

UA researchers discover promising lead in genetic approach to treating deadly brain cancer

Researchers discover pathway for enhancing the self-repair efforts of injured kidneys

Platelets grown from stem cells could reduce the reliance on donated platelets

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

Researchers examine the experiences of veterans receiving both cancer treatment and hospice care

New nanoscale technique developed to get more information from the blood of cancer patients

New therapeutic drug monitoring service could benefit children with cancer

Study: Some bowel cancer patients in the UK have to wait more than a year to begin treatment

Research may pave way for development of potent weapons against cancer

Scientists identify key component of microscopic machinery that drives cell death

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

FDA approves new treatment for AML patients

Mannose - nutritional supplement, could slow some cancers

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Colorectal cancer screening reduces need for intense treatments among male patients

Survey: Misconceptions about opioid use undermine pain control among Asian cancer patients

Study warns that potential epigenetic therapy may boost lung cancer stem cells

Cancer Research - Second Edition eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in